Candida lusitaniae : Biology, Pathogenicity, Virulence Factors, Diagnosis, and Treatment.
Diana F Mendoza-ReyesManuela Gómez-GaviriaHéctor Manuel Mora-MontesPublished in: Infection and drug resistance (2022)
The incidence of fungal infections is increasing at an alarming rate and has posed a great challenge for science in recent years. The rise in these infections has been related to the increase in immunocompromised patients and the resistance of different species to antifungal drugs. Infections caused by the different Candida species, especially Candida albicans , are one of the most common mycoses in humans, and the etiological agents are considered opportunistic pathogens associated with high mortality rates when disseminated infections occur. Candida lusitaniae is considered an emerging opportunistic pathogen that most frequently affects immunocompromised patients with some comorbidity. Although it is a low-frequency pathogen, and the mortality rate of C. lusitaniae -caused candidemia does not exceed 5%, some isolates are known to be resistant to antifungals such as amphotericin B, 5-fluorocytosine, and fluconazole. In this paper, a detailed review of the current literature on this organism and its different aspects, such as its biology, possible virulence factors, pathogen-host interaction, diagnosis, and treatment of infection, is provided. Of particular interest, through Blastp analysis we predicted possible virulence factors in this species.
Keyphrases
- candida albicans
- biofilm formation
- escherichia coli
- pseudomonas aeruginosa
- antimicrobial resistance
- staphylococcus aureus
- end stage renal disease
- risk factors
- genetic diversity
- cardiovascular events
- systematic review
- newly diagnosed
- ejection fraction
- public health
- chronic kidney disease
- prognostic factors
- cardiovascular disease
- type diabetes
- drug induced
- multidrug resistant